Summarized by Plex Health
Last Updated: 10 May 2022
the effect of bevacizumab on corneal neovascularization in rabbits. "the effect of bevacizumab on corneal neovascularization in rabbits.", by Kim WJ, Jeong HO, Chung SK. F1: Microscopic examination of the neovascularized area in the cornea. (A,B,C) Control group. (D,E,F) Group treated with topical 5 mg/mL bevacizumab. (G,H,I) Group treated with topical 10 mg/mL bevacizumab. (J,K,L) Group treated with subconjunctival bevacizumab...

Bevacizumab is a vascular endothelial development element prevention. Bevacizumab is also being researched in the therapy of other types of cancer. Definition from the NCI Drug Dictionary, Detailed scientific interpretation and other names for this medication. Drugs are frequently examined to discover if they can help deal with or protect against problems besides the ones they are authorized for. This patient information sheet applies only to approved uses the drug. Much of the information may use to unapproved uses that are being examined. Targeted Cancer Therapies. Atezolizumab Plus Bevacizumab Approved to Treat Liver Cancer. PARP Inhibitors Show Promise as Initial Treatment for Ovarian Cancer. Monoclonal Antibodies.

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions

** If you believe that content on the Plex is summarised improperly, please, contact us, and we will get rid of it quickly; please, send an email with a brief explanation.

PubChem - CovalentUnitCount

(Table source)
*** If you want us to remove all links leading to your domain from and never use your website as a source of the "Online Knowledge", please contact us using a corporate email and we will remove everything in 10 business days.


Plex Page is a Biology & Health Sciences "Online Knowledge Base," where a machine summarizes all the summaries.